SYRE Market Cap & Key Metrics
Spyre Therapeutics, Inc.
$83.73
+$3.83(+4.79%)
43
Overall
60
Value
50
Tech
21
Quality
Market Cap
$7.13B
Volume
299.40K
52W Range
$15.86 - $110.18
Target Price
$118.60
SYRE market cap is $7.13B. This page lists Spyre Therapeutics, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
SYRE Key Metrics
- Market cap
- $7.13B
- EPS estimate, current year
- $-2.71
- EPS growth, 3-year
- +56.91%
- Value score
- 60
- Quality score
- 21
- Technical score
- 50
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | - | - | $886.0K | $2.33M | $18.74M |
| EBITDA | -$165.22M | -$207.97M | -$354.30M | -$81.99M | -$64.07M |
| EPS | $-1.98 | - | $-49.12 | $-24.75 | $-25.00 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SYRE | $83.73 | +4.8% | 299.40K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Spyre Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW